===== GMO Regulation ===== !FIXME! The EU has one of the strictest regulatory frameworks for genetically modified organisms (GMOs) in the world. It applies to GM algae in both contained use research and deliberate environmental release scenarios, and to GM algae or GM algae-derived products used in food and feed. This chapter covers the four principal EU instruments governing GM algae and clarifies the boundaries between them. ---- ==== Overview: Four Instruments, Different Scenarios ==== EU GMO regulation operates through four main instruments, each addressing a different scenario: - __Contained use of GMMs__ (Directive 2009/41/EC) — laboratory and industrial-scale use of genetically modified micro-organisms in contained facilities, with no deliberate release. - __Deliberate environmental release__ (Directive 2001/18/EC) — field trials or commercial cultivation of GM organisms in open environments. - __GM food and feed__ (Regulation (EC) No 1829/2003) — placing on the market of GM food and feed, or food/feed derived from or containing GMOs. - __GMO traceability and labelling__ (Regulation (EC) No 1830/2003) — horizontal requirements for labelling and traceability of all GMOs and products derived from them. Which instrument applies depends on whether the GM algae is being used in contained conditions (research or industrial biotechnology), released into the environment, or commercialised as food/feed. ---- ==== Contained Use of GM Micro-organisms ==== Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms (recast), OJ L 125, 21.5.2009, p. 75. __Relevance to algae:__ Microalgae are micro-organisms for the purposes of this Directive, and genetically modified microalgae used in contained facilities (laboratories, bioreactors from which no release to the environment is possible) are governed by this Directive. Key provisions: * GM micro-organisms are classified into two classes (Class 1 and Class 2) based on risk, using criteria in Annex II. Most research microalgae strains would fall into Class 1 (low or negligible risk). * Users must carry out a risk assessment (Annex III) covering the properties of the recipient organism, the nature of the genetic modification, and the potential for release. * Containment measures (physical, chemical, biological) appropriate to the risk class must be implemented (Annex IV). * __Notification or consent__ to the competent national authority is required before commencing work, with the level of notification (simple notification vs. consent) depending on the risk class and the novelty of the work. * Records must be maintained; the competent authority may inspect facilities. For algae companies: * Research using GM microalgae in enclosed photobioreactors or laboratory settings falls under this Directive. * Industrial production of algae-derived products using GM microalgae as the production organism — where the microalgae themselves are not intended for release or for use in food/feed — also falls under this Directive (Class 2 use in most cases, potentially higher depending on scale and risk assessment). * The biotech algae industry (e.g. metabolic engineering of microalgae for improved lipid production, or cyanobacteria engineered for specialised product biosynthesis) operates primarily under this framework. ---- ==== Deliberate Environmental Release ==== Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms, OJ L 106, 17.4.2001, p. 1. __Relevance to algae:__ This Directive applies when a GM organism is deliberately released into the environment outside of a contained facility. For algae, this scenario arises if: * A GM algal strain is cultivated in open ponds, open water systems, or other open environments where environmental release cannot be prevented. * A field trial is conducted with a GM macroalgal cultivation system in coastal or estuarine waters. The Directive distinguishes: * __Part B — Trial releases__ (experimental introductions): notification to and consent from the national competent authority required, including environmental risk assessment, monitoring plan, and emergency response plan. * __Part C — Placing on the market__ (commercial introduction): EU-wide risk assessment through the Commission and EFSA, followed by Commission-level decision. This is an extremely demanding pathway. In practice, the EU has authorised very few GM organisms for deliberate environmental release, and none have been algae to date. The pathway for a commercial GM algae open-cultivation system in the EU is effectively impractical under current law. For closed-system production (photobioreactors with appropriate containment), the contained use Directive (2009/41/EC) applies instead. ---- ==== GM Food and Feed ==== Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, OJ L 268, 18.10.2003, p. 1. __Relevance to algae:__ If a GM algal organism or a product derived from a GM algal organism is intended for use as food or feed, this Regulation applies. A product is covered if it: * Consists of or contains a GMO (e.g. whole or processed GM algae biomass); or * Is produced from GMOs (e.g. an oil extracted from a GM algal strain), even if the final product contains no detectable GM material. The authorisation procedure requires: * Application to the national competent authority, forwarded to EFSA. * EFSA safety assessment (nutritional, toxicological, environmental risk components). * Commission implementing decision granting (or refusing) authorisation. * If authorised, the product is added to the EU register of authorised GM food and feed. Labelling as "genetically modified" is required for food and feed products that consist of or contain GMOs, or that are produced from GMOs and above the 0.9% threshold (for adventitious or technically unavoidable presence). Products "produced from GMOs but not containing or consisting of GMOs" (e.g. highly refined oil from GM algae) may not require labelling if below the threshold. The authorisation pathway under Regulation (EC) No 1829/2003 is very demanding — only a relatively small number of GM food/feed products are authorised in the EU, all of them for import/processing purposes (principally GM maize and soybean). No GM algae-derived food or feed product has been authorised to date. ---- ==== Novel Food and GMO Boundary ==== Regulation (EU) 2015/2283 on novel foods (see [[algae:food:novel_food|Novel Food]]) explicitly excludes from its scope food produced from GMOs falling within the scope of Regulation (EC) No 1829/2003. The two frameworks are therefore mutually exclusive: a GM algae food product is assessed under the GM food regulation, not the novel food regulation. The distinction is important because the two authorisation pathways differ significantly in their data requirements and procedural rules. ---- ==== New Genomic Techniques ==== Regulation (EU) 2025/... on plants obtained by certain new genomic techniques (NGTs) and food and feed derived from them (adopted 2025 — check EUR-Lex for current OJ reference). __Relevance to algae:__ The EU has recently adopted a new Regulation on "new genomic techniques" (NGTs, including CRISPR/Cas9-based techniques) for plants, which creates a lighter-touch regulatory pathway for plants with targeted genetic modifications equivalent to what could have occurred through conventional breeding. The new NGT Regulation covers plants (category covering algae is to be interpreted in light of whether algae qualify as "plants" for this regulatory purpose — see [[algae:purpose_scope_sources|Purpose, Scope and Sources]] for the definitional question); the position of algae under the NGT Regulation requires careful legal analysis as implementing measures are developed. If the NGT Regulation is interpreted to cover microalgae engineered through targeted mutagenesis techniques, it would create a significantly more accessible pathway for commercialising certain types of precision-edited microalgae than the classical GMO framework. This is an area to monitor closely. ---- ==== Practical Implications for Producers ==== * __Contained-use GM microalgae research and industrial production__ is the most realistic GMO-relevant scenario for the algae sector currently; ensure the Directive 2009/41/EC notification/consent requirements are met before starting GM microalgae work. * __Open-environment GM algae cultivation__ is not currently a viable commercial pathway in the EU under the deliberate release framework. * __GM algae food/feed__ faces an extremely demanding authorisation pathway with no approved precedent; do not plan commercial timelines on the basis that EU GM food approval is achievable in the near term. * __NGT developments__ may create opportunities for commercially relevant precision-edited algae strains — engage with the regulatory framework as it is implemented through delegated and implementing acts. * __Novel food / GMO boundary__: if developing a GM algae product with potential food use, clarify early which framework applies — novel food or GM food. ---- //See also: [[algae:food:novel_food|Novel Food]] | [[algae:environment_alien_species|Environment and Use of Non-native Species]] | [[algae:intellectual_property|Intellectual Property]] | [[algae:purpose_scope_sources|Purpose, Scope and Sources]]// //Last reviewed: June 2026.//